Santosha A. Vardhana

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

S. A Vardhana, S. A. Vardhana, S. Vardhana, Santosh A. Vardhana, Santosh Vardhana, Santosha Vardhana, Santosha A Vardhana, Santosha A. Vardhana, Santosha Adipudi Vardhana, Santosha Vardhana

250

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University New York University Parker Institute for Cancer Immunotherapy Harvard University

About

Santosha A. Vardhana is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	31	3K
2	Cell Biology	13	13	1.7K
3	Public Health	8	8	433
4	Natural Sciences	2	2	201
5	Biomedical Engineering	1	1	17

Santosha A. Vardhana

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
The many faces of the anti-COVID immune response Santosha A. Vardhana, Jedd D. Wolchok The Journal of Experimental Medicine VaccinationHost ResponseMortality WorldwideCovid-19 PandemicImmunology	2020	538
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Erin M. Bange, Nicholas Han, Paul Wileyto, Nature Medicine	2021	503
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen Santosha A. Vardhana, Madeline A. Hwee, Mirela Berisa, Nature Immunology Autoimmune DiseaseMitochondrial FunctionT CellsPersistent AntigenT-regulatory Cell	2020	489
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence Julia A. Belk, Winnie Yao, Nghi Ly, Cancer Cell ChromatinChromatin RemodelingGeneticsGenome-wide Crispr ScreensGene Editing	2022	316
T cell antigen receptor signaling and immunological synapse stability require myosin IIA Tal Ilani, Gaia Vasiliver-Shamis, Santosha A. Vardhana, Nature Immunology Signal TransductionAutoimmune DiseaseMyosin IiaMedicineT-regulatory Cell	2009	218
Galectin-3 negatively regulates TCR-mediated CD4<sup>+</sup>T-cell activation at the immunological synapse Huan‐Yuan Chen, Agnes Fermin, Santosha A. Vardhana, Proceedings of the National Academy of Sciences	2009	189
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Journal of Clinical Oncology	2021	183
Essential Role of Ubiquitin and TSG101 Protein in Formation and Function of the Central Supramolecular Activation Cluster Santosha A. Vardhana, Kaushik Choudhuri, Rajat Varma, Immunity Protein FunctionSignal TransductionEssential RoleProtein AssemblyNatural Sciences	2010	166
Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome Sriram C. Perni, Santosha A. Vardhana, Irina Korneeva, American Journal of Obstetrics and Gynecology Maternal ImmunizationInfertilityUrologyMycoplasma HominisGynecology	2004	164
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen, Blood	2021	159

Page 1